-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
January 01, 2022 - Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update
Comparative Effectiveness Review
Number 250
Living Systematic Review on Cannabis and
Other Plant-Based Treatments for Chronic
Pain: 2022 Update
Evide…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
January 01, 2013 - Depression SSRI Surveillance Assessment_CER 62_Low-1
CER # 62: Treatment of Depression after Unsatisfactory
Response to SSRIs
Original release date: April 2012
Surveillance Report: January 2013
Key Findings:
• All conclusions are up to date.
Summary Decision
This CER’s priority for updati…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - Layout 1
Background
Gastroesophageal reflux disease (GERD) is
one of the most common health conditions
affecting Americans. A study of an
employed population in the United States
estimated that more than 11,000 of 267,000
employees (4 percent) suffered from
GERD, contributing an average
incremental cost to the emplo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States
Evidence-based Practice Center Systematic Review Protocol
Project Title: Safety of Vaccines Used for Routine Immunization in the United States
I. Background and Objectives for the Systematic Review
Vaccines are consi…
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - PULMONARY with "Discussions" in Exec Summary
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 13: Pulmonary Disease, Including Asthma
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
September 01, 2009 - Layout 1
Background
Breast cancer is the most frequently
diagnosed noncutaneous cancer and the
second leading cause of cancer death after
lung cancer among women in the United
States. In 2008, an estimated 182,460 cases
of invasive breast cancer and 67,770 cases
of in situ breast cancer were diagnosed, and
40,480 wo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
September 01, 2014 - Developmental Delays
Autism Spectrum Disorder
Clinician Research Summary
Comparative Effectiveness of Therapies for Children With Autism
Spectrum Disorder
Key Clinical Issue
What evidence is available regarding the effectiveness, benefits, and harms of therapies used to address the core and
associated symptoms seen…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
May 01, 2013 - What are the significant safety concerns associated
with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated
with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated
with each treatment strategy (e.g., adverse
drug … drug reactions (KQ 2 and
KQ 3, especially the exercise, endovascular, and
surgical therapies)
Insufficient … drug reactions was sparse in these studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
January 01, 2015 - Medication use leading
to emergency department visits for adverse drug events in older
adults.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
June 01, 2014 - PEPTIC ULCER #11
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 11: Peptic Ulcer Disease and Dyspepsia
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
ww…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
November 01, 2012 - 1
Comparative Effectiveness Review
Number 76
Treatment for Hepatitis C Virus
Infection in Adults
Executive Summary
Background
Hepatitis C virus (HCV) is the most
common chronic bloodborne
pathogen in the United States. HCV
is primarily acquired by large or
repeated percutaneous exposures to
blood, with …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
July 01, 2016 - Treatments for Fecal Incontinence: Current State of the Evidence
Treatments for Fecal Incontinence: Current State
of the Evidence
Focus of This Summary
This is a summary of a systematic review evaluating the evidence regarding the potential benefits and adverse effects of
surgical and nonsurgical treatments for f…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
December 05, 2018 - Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions
Evidence-based Practice Center Systematic Review Protocol
Project Title: Maternal and Fetal Effects of Mental Health Treatments in Pregnant
and Breastfeeding …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
November 01, 2017 - Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary
Comparative Effectiveness Review
Number 193
Effective Health Care Program
Management of Suspected Opioid Overdose
With Naloxone by Emergency Medical
Services Personnel
Executive Summary
Background…
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
January 01, 2009 - exclusion rates Run-in period: attrition rate before randomization and reasons (e.g., nonadherence, adverse … drug events, no response)
Events rates markedly different than in community Event rates in treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
November 27, 2012 - Disposition of Comments Report for Treatment for Hepatitis C Virus Infection in Adults
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1298
Published Online: November 27, 2012
Comparative Effectiveness Research Review Disposition of Comm…
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - Diabetes Mellitus
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 07: Diabetes Mellitus
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
April 01, 2022 - Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2
Systematic Review on Opioid
Treatments for Chronic Pain:
Surveillance Report 2
Literature Update Period: October 2021 through November 2021
Background and Purpose
This is the second surveillance report for the 2020 report Opioid Trea…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - CER # 37:
Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and
Treatment
Original release date:
January 2012
Surveillance Report:
October 2012
Key Findings:
- The conclusions for KQ2 (harms of screening) and KQ4
(harms of monitoring), KQ6 (harms of treatment) are still
considered valid
- T…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_clinician.pdf
March 01, 2016 - outcomes, including slowed
evolution of antibiotic resistance, decreased health care
costs, and fewer adverse … drug events.